Sickle-cell beta thalassemia
Thalassemia Hb-S disease
Hemolytic anemia, in which patients are heterozygous for both the sickle cell gene and a thalassemia gene.
D57.4 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2023 edition of ICD-10-CM D57.4 became effective on October 1, 2022.
This is the American ICD-10-CM version of D57.4 – other international versions of ICD-10 D57.4 may differ.